Daniela Niepel

1.4k total citations
27 papers, 891 citations indexed

About

Daniela Niepel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Daniela Niepel has authored 27 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Hematology. Recurrent topics in Daniela Niepel's work include Bone health and treatments (20 papers), Cancer Diagnosis and Treatment (9 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Daniela Niepel is often cited by papers focused on Bone health and treatments (20 papers), Cancer Diagnosis and Treatment (9 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Daniela Niepel collaborates with scholars based in Switzerland, Italy and Austria. Daniela Niepel's co-authors include Tim Van den Wyngaert, Morten Schiødt, Christoph Pautke, Sven Otto, Carla Ripamonti, Roger von Moos, Luís Costa, Jean‐Jacques Body, Lawrence Drudge‐Coates and Rui Amaral Mendes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Daniela Niepel

27 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Niepel Switzerland 13 660 340 156 139 128 27 891
Devchand Paul United States 16 819 1.2× 224 0.7× 203 1.3× 58 0.4× 171 1.3× 34 1.0k
Massimo Maniezzo Italy 9 555 0.8× 346 1.0× 122 0.8× 58 0.4× 123 1.0× 15 717
Sheila Piva Italy 11 314 0.5× 133 0.4× 123 0.8× 86 0.6× 35 0.3× 27 588
Andrea Keck Austria 9 293 0.4× 152 0.4× 102 0.7× 36 0.3× 74 0.6× 16 484
Rebecca Pedersini Italy 15 306 0.5× 95 0.3× 180 1.2× 95 0.7× 32 0.3× 41 551
Virginia Dalton United States 10 443 0.7× 84 0.2× 242 1.6× 80 0.6× 194 1.5× 17 1.7k
Moira Cheung United Kingdom 22 294 0.4× 245 0.7× 125 0.8× 174 1.3× 24 0.2× 60 1.2k
Luísa Pinto Portugal 7 352 0.5× 42 0.1× 152 1.0× 214 1.5× 129 1.0× 26 704
Nuno Bonito Portugal 6 395 0.6× 42 0.1× 167 1.1× 207 1.5× 132 1.0× 20 696
Martin Biosse Duplan France 15 334 0.5× 127 0.4× 145 0.9× 120 0.9× 22 0.2× 31 1.3k

Countries citing papers authored by Daniela Niepel

Since Specialization
Citations

This map shows the geographic impact of Daniela Niepel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Niepel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Niepel more than expected).

Fields of papers citing papers by Daniela Niepel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Niepel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Niepel. The network helps show where Daniela Niepel may publish in the future.

Co-authorship network of co-authors of Daniela Niepel

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Niepel. A scholar is included among the top collaborators of Daniela Niepel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Niepel. Daniela Niepel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olesen, Tina Bech, Ina Trolle Andersen, Anne Gulbech Ording, et al.. (2021). Use of bisphosphonates in multiple myeloma patients in Denmark, 2005–2015. Supportive Care in Cancer. 29(8). 4501–4511. 1 indexed citations
2.
Diel, Ingo, et al.. (2020). Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany. Supportive Care in Cancer. 28(11). 5223–5233. 20 indexed citations
3.
Mateos, María‐Victoria, et al.. (2020). Bone complications in patients with multiple myeloma in five European countries: a retrospective patient chart review. BMC Cancer. 20(1). 170–170. 17 indexed citations
4.
Haslbauer, Ferdinand, Andreas Petzer, Antoaneta Tomova, et al.. (2019). Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis. Supportive Care in Cancer. 28(4). 1855–1865. 5 indexed citations
5.
Peters, Solange, Philippe Clézardin, Iván Márquez‐Rodas, Daniela Niepel, & Craig Gedye. (2019). The RANK–RANKL axis: an opportunity for drug repurposing in cancer?. Clinical & Translational Oncology. 21(8). 977–991. 24 indexed citations
6.
Drudge‐Coates, Lawrence, et al.. (2019). Management of bone health in patients with cancer: a survey of specialist nurses. Supportive Care in Cancer. 28(3). 1151–1162. 6 indexed citations
7.
Moos, Roger von, Luís Costa, Eva González‐Suárez, et al.. (2019). Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody. Cancer Treatment Reviews. 76. 57–67. 101 indexed citations
8.
Liede, Alexander, et al.. (2018). Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect. Breast Cancer Research and Treatment. 171(2). 435–442. 68 indexed citations
9.
Otto, Sven, Christoph Pautke, Tim Van den Wyngaert, Daniela Niepel, & Morten Schiødt. (2018). Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treatment Reviews. 69. 177–187. 201 indexed citations
10.
Body, Jean‐Jacques, Roger von Moos, Daniela Niepel, & Bertrand Tombal. (2018). Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion. BMC Urology. 18(1). 81–81. 12 indexed citations
11.
Saad, Fred, Cora N. Sternberg, Peter F.A. Mulders, Daniela Niepel, & Bertrand Tombal. (2018). The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer. Cancer Treatment Reviews. 68. 25–37. 28 indexed citations
12.
Brodowicz, Thomas, Peyman Hadji, Daniela Niepel, & Ingo Diel. (2017). Early identification and intervention matters: A comprehensive review of current evidence and recommendations for the monitoring of bone health in patients with cancer. Cancer Treatment Reviews. 61. 23–34. 26 indexed citations
13.
Shahinian, Vahakn B., Amit Bahl, Daniela Niepel, & Vito Lorusso. (2017). Considering renal risk while managing cancer. Cancer Management and Research. Volume 9. 167–178. 12 indexed citations
14.
Body, Jean‐Jacques, Daniela Niepel, & Giuseppe Tonini. (2017). Hypercalcaemia and hypocalcaemia: finding the balance. Supportive Care in Cancer. 25(5). 1639–1649. 23 indexed citations
15.
Mateos, M.V., Michèle Cavo, Louis M. Fink, et al.. (2017). Patient Characteristics, Skeletal Related Events (SRE) And Renal Impairment (RI) In Patients With Multiple Myeloma (MM): A Patient Chart Audit In EU5. Value in Health. 20(9). A413–A413. 2 indexed citations
16.
Mądry, Radosław, Ferdinand Haslbauer, Tibor Csőszi, et al.. (2016). Results of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy. Wiener klinische Wochenschrift. 128(7-8). 238–247. 9 indexed citations
17.
Lüftner, Diana & Daniela Niepel. (2016). Breast cancer and bone metastases: a call for appropriate treatment. Supportive Care in Cancer. 24(10). 4075–4077. 1 indexed citations
18.
Moos, Roger von, Luís Costa, Carla Ripamonti, Daniela Niepel, & Daniele Santini. (2016). Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain. European Journal of Cancer. 71. 80–94. 69 indexed citations
19.
Moos, Roger von, Giorgio V. Scagliotti, H.P. Sleeboom, et al.. (2016). Symptomatic skeletal events (SSEs) versus skeletal-related events (SREs) in patients with advanced cancer and bone metastases treated with denosumab or zoledronic acid. Annals of Oncology. 27. vi507–vi507. 3 indexed citations
20.
Schadt, Oliver, et al.. (2006). New polyamine-sensitive inhibitors of the NMDA receptor: Syntheses and pharmacological evaluation. European Journal of Medicinal Chemistry. 42(2). 175–197. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Devchand Paul Breakdown of academic impact, for papers by Massimo Maniezzo Breakdown of academic impact, for papers by Sheila Piva Breakdown of academic impact, for papers by Andrea Keck Breakdown of academic impact, for papers by Rebecca Pedersini Breakdown of academic impact, for papers by Virginia Dalton Breakdown of academic impact, for papers by Moira Cheung Breakdown of academic impact, for papers by Luísa Pinto Breakdown of academic impact, for papers by Nuno Bonito Breakdown of academic impact, for papers by Martin Biosse Duplan
Rankless by CCL
2026